translate English to French: At the FDA, 21 CFR 201.10( c)(5) is the basis for the safety review of LA/SA drug names.
T. G. Phillips, «DMETS Evaluation of Proprietary Names», Proc. of Evaluating Drug Names for Similarities: Methods and Approaches Public Meeting, Washington D.C., le 26 juin 2003.